Towards Healthcare
U.S. Clinical Trials Market Drives USD 80.42 billion by 2035

U.S. Clinical Trials Market Expands With Increasing Demand for Novel Therapies

According to market projections, the U.S. clinical trials sector is expected to grow from USD 43.45 billion in 2025 to USD 80.42 billion by 2035, reflecting a CAGR of 6.35%. The U.S. clinical trials market is growing due to rising government investment and rising collaboration among key players.

Content

  • Last Updated: 26 November 2025
  • Report Covered: [Revenue + Volume]
  • Historical Year: 2021-2023
  • Base Year: 2024
  • Estimated Years: 2025-2034

About The Author

Rohan Patil is a seasoned market research professional with over 5 years of focused experience in the healthcare sector, bringing deep domain expertise, strategic foresight, and analytical precision to every project he undertakes.

He began his journey with Precedence Research, where he played a pivotal role in developing high-impact healthcare market reports. Today, Rohan leads research initiatives at Towards Healthcare, while also contributing to Statifacts, where he supports cross-industry analysis and data-driven storytelling.

Rohan’s core strengths lie in trend analysis and emerging technologies, regulatory monitoring and thought leadership through high-quality report writing. He excels at identifying future-ready opportunities and translating complex data into strategic recommendations. His work spans pharmaceuticals, biotechnology, medical devices, and digital health, assessing everything from market potential and competitive positioning to customer needs and regulatory shifts.

A trusted advisor and a relentless innovator, Rohan continues to push the boundaries of traditional market research, merging scientific rigor with commercial insight to stay ahead in a fast-evolving healthcare landscape.

Talk to us
FAQ's

The U.S. clinical trials market in 2026 is valued at USD 46.21 billion and is projected to climb to USD 80.42 billion by 2035, with a CAGR of 6.35% over the forecast period.

The U.S. clinical trials market includes 4 segments such as phase, study design, indication, and region.

Some key players include IQVIA, Thermo Fisher Scientific PPD, LabCorp Covance, ICON plc, Parexel, Syneos Health, etc.

Key trends include rising demand for biologics and vaccines for cancer therapy.

No, listing studies on ClinicalTrials.gov is free. Through the National Library of Medicine, the National Institutes of Health offers ClinicalTrials.gov, a free service.

National Institutes of Health, FDA, WHO, CDC, National Cancer Institute, American Cancer Society, MDPI, NIH, National Library of Medicine, ClinicalTrials.gov.
Any Questions